Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
08:13am, Monday, 31'st Oct 2022 Benzinga
Gainers
Quanergy Systems, Inc. (NASDAQ: QNGY) jumped 153.9% to close at $3.30 on Friday.
Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) surged 61.4% to close at $0.92 after jumping 15% on Thursday.
Nuva
PacBio to Report Third Quarter Earnings on November 7 and Host Inaugural Investor Day on November 15
10:29pm, Tuesday, 25'th Oct 2022
Withdraws Guidance with New Product Announcement MENLO PARK, Calif. , Oct. 25, 2022 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its
PacBio's (PACB) Latest Offering to Enhance Genome Sequencing
02:10pm, Monday, 24'th Oct 2022 Zacks Investment Research
PacBio's (PACB) latest sequencing panels are expected to simplify the study of the difficult-to-sequence or accurately map genomes, thereby aiding researchers.
PacBio's (PACB) Latest Offering to Enhance Disease Discoveries
01:20pm, Monday, 24'th Oct 2022 Zacks Investment Research
PacBio's (PACB) latest sequencing kit is expected to help generate insights into how single-cell research can power new disease discoveries and the identification of therapeutic targets across many ca
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
09:37am, Monday, 24'th Oct 2022 Benzinga
Gainers
Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.
Altamira Therapeutics Ltd. (NASDAQ: CYTO) climbed 58.6% to close at $0.5197 on Friday after the c
Moderna, Amazon, Tesla, And Other Big Gainers From Friday
08:19am, Monday, 24'th Oct 2022 Benzinga
U.S. stocks closed higher on Friday, with the Dow Jones gaining around 750 points. Here is the list of some big stocks recording gains in the previous session.
Huadi International Group Co., Ltd. (NA
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q3 2022 Update
07:10am, Wednesday, 19'th Oct 2022 Seeking Alpha
ARK Invest’s 13F portfolio value decreased from $16.91B to $14.35B this quarter. Click to see the firm's trades for Q3 2022.
Why Norwegian Cruise Line Shares Climbed By Around 12%; Here Are 66 Biggest Movers From Yesterday
10:06am, Thursday, 13'th Oct 2022 Benzinga
Gainers
Pintec Technology Holdings Limited (NASDAQ: PT) shares jumped 216.2% to close at $0.9058 on Wednesday.
Agrify Corporation (NASDAQ: AGFY) climbed 88% to close at $ 0.9540 on Wednesday after cl
Moderna, BioNTech And Some Other Big Stocks Moving Higher On Wednesday
02:28pm, Wednesday, 12'th Oct 2022 Benzinga
U.S. stocks traded mostly higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording gains in today’s session.
FLJ Group Limited (NASDAQ: FLJ) shares j
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
09:09am, Thursday, 29'th Sep 2022 Benzinga
Gainers
PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The tria
PacBio's (PACB) New Method for TR Profiling Now Available
05:08pm, Wednesday, 28'th Sep 2022 Zacks Investment Research
PacBio's (PACB) latest tool is expected to enable scientists to better understand the role of known TRs in human disease, which could also lead to the discovery of novel disease-causing TRs.
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
04:40pm, Wednesday, 28'th Sep 2022 Benzinga
Gainers
Prothena Corporation plc (NASDAQ: PRTA) shares climbed 76.4% to $54.54 after Biogen and Eisai Co. Ltd. announced late Tuesday positive results from a late-stage study of their Alzheimer’s
PacBio's (PACB) New Method for TR Profiling Now Available
02:18pm, Wednesday, 28'th Sep 2022
PacBio's (PACB) latest tool is expected to enable scientists to better understand the role of known TRs in human disease, which could also lead to the discovery of novel disease-causing TRs.
3 Reasons to Retain PacBio (PACB) Stock in Your Portfolio
12:02pm, Wednesday, 21'st Sep 2022 Zacks Investment Research
PacBio's (PACB) strength in its Sequel system raises optimism about the stock.
3 Reasons to Retain PacBio (PACB) Stock in Your Portfolio
09:47am, Wednesday, 21'st Sep 2022
PacBio's (PACB) strength in its Sequel system raises optimism about the stock.
